share_log

上海荣正企业咨询服务(集团)股份有限公司关于诺诚健华医药有限公司2024年科创板限制性股票激励计划首次授予事项之独立财务顾问报告

Independent Financial Advisory Report of Shanghai Rongzheng Enterprise Consulting Service (Group) Co., Ltd. on the first grant of Nuochengjianhua Pharmaceutical Co., Ltd.\'s 2024 Science and Technology Innovation Board Restricted Stock Incentive Plan

SZSI ·  Dec 17, 2024 11:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more